Buy Stocks Easy | About Us
February 19, 2020
Buy Stocks Easy | Online Stocks

AGLE


Buy Aeglea BioTherapeutics, Inc. Stock (symbol: AGLE) Easy Online

Company Name: Aeglea BioTherapeutics, Inc.

Symbol: AGLE

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2016

AGLE Current Share Price

Today's AGLE ( Aeglea BioTherapeutics, Inc. ) opening price: $7.5900

Yesterday's AGLE ( Aeglea BioTherapeutics, Inc. ) closing price: $7.6000

Aeglea BioTherapeutics, Inc. Stock ( symbol: AGLE ) Price Chart since IPO (2016):

12 Months Aeglea BioTherapeutics, Inc. Stock ( symbol: AGLE ) Price Chart

Popular Questions about Aeglea BioTherapeutics, Inc. Public Stock ( AGLE )

A: Aeglea BioTherapeutics, Inc. stock symbol (also called stock or share ticker) is AGLE

A: Aeglea BioTherapeutics, Inc. IPO (Initial Public Offering) took place on 2016

A: Aeglea BioTherapeutics, Inc.'s stock (AGLE symbol) price at ther IPO (initial Public Offering) was $7.5900

Q: Is AGLE stock worth buying at the moment?

A: The AGLE stock performance since 2019 are rather disappointing. If you had bought 1 share of Aeglea BioTherapeutics, Inc. stock (symbol: AGLE) at the beginning of 2019, at the opening share price of $9.1400, you would be left with exactly $7.5900 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Aeglea BioTherapeutics, Inc. Stock Easy Online

Aeglea BioTherapeutics, Inc. Stock Ticker Price Chart since IPO:





Aeglea BioTherapeutics, Inc. Stock Price Yesterday



 


Aeglea BioTherapeutics, Inc. Stock Price – Last Week




 


Aeglea BioTherapeutics, Inc. Stock Price – Last Month




 


Aeglea BioTherapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/04/1940245/0/en/Aeglea-BioTherapeutics-Strengthens-Leadership-Team-with-Appointment-of-Ravi-M-Rao-as-Chief-Medical-Officer-and-Michael-C-Hanley-as-Chief-Commercial-Officer.html
                            

                                
Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C.

                                
                                
AUSTIN, Texas, Nov.  04, 2019  (GLOBE NEWSWIRE) -- Aeglea BioTherap...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911499/0/en/Aeglea-BioTherapeutics-to-Present-at-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference

                                
                                
Live Webcast Scheduled for 5:30 p.m. ET on Monday, September 9 Live...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1909793/0/en/Aeglea-BioTherapeutics-Announces-Positive-20-Dose-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-at-the-2019-SSIEM-Symposium.html
                            

                                
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

                                
                                
Sustained Control of Plasma Arginine Accompanied by Clinical Respon...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/29/1908394/0/en/Aeglea-BioTherapeutics-to-Present-New-20-Dose-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-at-2019-SSIEM-Symposium.html
                            

                                
Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium

                                
                                
Management to Host Conference Call at 9:00 a.m. ET on Tuesday, Sept...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4278878-aeglea-biotherapeutics-investment-potential-addressing-unmet-need?source=feed_tag_long_ideas
                            

                                
Aeglea BioTherapeutics: Investment Potential Addressing Unmet Need

                                
                                
The stock has gained 15% during the past month due to insider buying.


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/894660/aeglea-biotherapeutics-inc-agle-president--ceo-anthony-g-quinn-bought-196535-of-shares
                            

                                
Aeglea Biotherapeutics Inc (AGLE) President & CEO Anthony G. Quinn Bought $196,535 of Shares

                                
                                
President & CEO of Aeglea Biotherapeutics Inc (NASDAQ:AGLE) Anthony...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/372396/aeglea-agle-reports-new-positive-data-for-pegzilarginase
                            

                                
Aeglea Reports New Positive Data for Pegzilarginase

                                
                                
Aeglea reports new positive data for pegzilarginase in patients wit...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/04/1940245/0/en/Aeglea-BioTherapeutics-Strengthens-Leadership-Team-with-Appointment-of-Ravi-M-Rao-as-Chief-Medical-Officer-and-Michael-C-Hanley-as-Chief-Commercial-Officer.html
                            

                                
Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C.

                                
                                
AUSTIN, Texas, Nov.  04, 2019  (GLOBE NEWSWIRE) -- Aeglea BioTherap...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911499/0/en/Aeglea-BioTherapeutics-to-Present-at-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference

                                
                                
Live Webcast Scheduled for 5:30 p.m. ET on Monday, September 9 Live...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1909793/0/en/Aeglea-BioTherapeutics-Announces-Positive-20-Dose-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-at-the-2019-SSIEM-Symposium.html
                            

                                
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

                                
                                
Sustained Control of Plasma Arginine Accompanied by Clinical Respon...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/29/1908394/0/en/Aeglea-BioTherapeutics-to-Present-New-20-Dose-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-at-2019-SSIEM-Symposium.html
                            

                                
Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium

                                
                                
Management to Host Conference Call at 9:00 a.m. ET on Tuesday, Sept...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4278878-aeglea-biotherapeutics-investment-potential-addressing-unmet-need?source=feed_tag_long_ideas
                            

                                
Aeglea BioTherapeutics: Investment Potential Addressing Unmet Need

                                
                                
The stock has gained 15% during the past month due to insider buying.


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/894660/aeglea-biotherapeutics-inc-agle-president--ceo-anthony-g-quinn-bought-196535-of-shares
                            

                                
Aeglea Biotherapeutics Inc (AGLE) President & CEO Anthony G. Quinn Bought $196,535 of Shares

                                
                                
President & CEO of Aeglea Biotherapeutics Inc (NASDAQ:AGLE) Anthony...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/372396/aeglea-agle-reports-new-positive-data-for-pegzilarginase
                            

                                
Aeglea Reports New Positive Data for Pegzilarginase

                                
                                
Aeglea reports new positive data for pegzilarginase in patients wit...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.